BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 38159995)

  • 21. A mitochondrial DNA mutation influences the apoptotic effect of statins on prostate cancer.
    Sun Q; Arnold RS; Sun CQ; Petros JA
    Prostate; 2015 Dec; 75(16):1916-25. PubMed ID: 26383260
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Statin derivatives as therapeutic agents for castration-resistant prostate cancer.
    Ingersoll MA; Miller DR; Martinez O; Wakefield CB; Hsieh KC; Simha MV; Kao CL; Chen HT; Batra SK; Lin MF
    Cancer Lett; 2016 Dec; 383(1):94-105. PubMed ID: 27687622
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative effects of high and low-dose simvastatin on prostate epithelial cells: the role of LDL.
    Murtola TJ; Syvälä H; Pennanen P; Bläuer M; Solakivi T; Ylikomi T; Tammela TL
    Eur J Pharmacol; 2011 Dec; 673(1-3):96-100. PubMed ID: 22040920
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Statin induces apoptosis and cell growth arrest in prostate cancer cells.
    Hoque A; Chen H; Xu XC
    Cancer Epidemiol Biomarkers Prev; 2008 Jan; 17(1):88-94. PubMed ID: 18199714
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preparation of nanobubbles carrying androgen receptor siRNA and their inhibitory effects on androgen-independent prostate cancer when combined with ultrasonic irradiation.
    Wang L; Zhang M; Tan K; Guo Y; Tong H; Fan X; Fang K; Li R
    PLoS One; 2014; 9(5):e96586. PubMed ID: 24798477
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adamantanyl-histone deacetylase inhibitor H6CAHA exhibits favorable pharmacokinetics and augments prostate cancer radiation sensitivity.
    Konsoula Z; Cao H; Velena A; Jung M
    Int J Radiat Oncol Biol Phys; 2011 Apr; 79(5):1541-8. PubMed ID: 21277099
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The radiation response of androgen-refractory prostate cancer cell line C4-2 derived from androgen-sensitive cell line LNCaP.
    Xie BX; Zhang H; Yu L; Wang J; Pang B; Wu RQ; Qian XL; Li SH; Shi QG; Wang LL; Zhou JG
    Asian J Androl; 2010 May; 12(3):405-14. PubMed ID: 20118949
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synergistic growth inhibition of PC3 prostate cancer cells with low-dose combinations of simvastatin and alendronate.
    Rogers M; Kalra S; Moukharskaya J; Chakraborty K; Niyazi M; Krishnan K; Lightner J; Brannon M; Stone WL; Palau VE
    Anticancer Res; 2015 Apr; 35(4):1851-9. PubMed ID: 25862838
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Arsenic trioxide enhances the radiation sensitivity of androgen-dependent and -independent human prostate cancer cells.
    Chiu HW; Chen YA; Ho SY; Wang YJ
    PLoS One; 2012; 7(2):e31579. PubMed ID: 22363680
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Piperine, a Bioactive Component of Pepper Spice Exerts Therapeutic Effects on Androgen Dependent and Androgen Independent Prostate Cancer Cells.
    Samykutty A; Shetty AV; Dakshinamoorthy G; Bartik MM; Johnson GL; Webb B; Zheng G; Chen A; Kalyanasundaram R; Munirathinam G
    PLoS One; 2013; 8(6):e65889. PubMed ID: 23824300
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antisense MDM2 enhances E2F1-induced apoptosis and the combination sensitizes androgen-sensitive [corrected] and androgen-insensitive [corrected] prostate cancer cells to radiation.
    Udayakumar TS; Hachem P; Ahmed MM; Agrawal S; Pollack A
    Mol Cancer Res; 2008 Nov; 6(11):1742-54. PubMed ID: 19010821
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interleukin-4 stimulates androgen-independent growth in LNCaP human prostate cancer cells.
    Lee SO; Pinder E; Chun JY; Lou W; Sun M; Gao AC
    Prostate; 2008 Jan; 68(1):85-91. PubMed ID: 18008330
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pin1 Inhibitor Juglone Exerts Anti-Oncogenic Effects on LNCaP and DU145 Cells despite the Patterns of Gene Regulation by Pin1 Differing between These Cell Lines.
    Kanaoka R; Kushiyama A; Seno Y; Nakatsu Y; Matsunaga Y; Fukushima T; Tsuchiya Y; Sakoda H; Fujishiro M; Yamamotoya T; Kamata H; Matsubara A; Asano T
    PLoS One; 2015; 10(6):e0127467. PubMed ID: 26039047
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chinese red yeast rice versus lovastatin effects on prostate cancer cells with and without androgen receptor overexpression.
    Hong MY; Seeram NP; Zhang Y; Heber D
    J Med Food; 2008 Dec; 11(4):657-66. PubMed ID: 19053857
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of proliferation and expression of AR/PSA by herbal supplement Equiguard in LNCaP cells cultured in androgen-proficient FBS and androgen-deficient charcoal-stripped FBS is correlated with increased serine-15 phosphorylation of the tumor suppressor gene p53.
    Lu X; Guo J; Hsieh TC; Wu JM
    Anticancer Res; 2003; 23(3B):2489-98. PubMed ID: 12894532
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Double-layer omics analysis of castration- and X-ray-resistant prostate cancer cells.
    Iwanaga M; Kawamura H; Kubo N; Mizukami T; Oike T; Sato H; Miyazawa Y; Sekine Y; Kawabata-Iwakawa R; Nishiyama M; Ohno T; Nakano T
    J Radiat Res; 2022 Jul; 63(4):585-590. PubMed ID: 35589101
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Doxorubicin induces prostate cancer drug resistance by upregulation of ABCG4 through GSH depletion and CREB activation: Relevance of statins in chemosensitization.
    Mallappa S; Neeli PK; Karnewar S; Kotamraju S
    Mol Carcinog; 2019 Jul; 58(7):1118-1133. PubMed ID: 30834613
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dissociation between androgen responsiveness for malignant growth vs. expression of prostate specific differentiation markers PSA, hK2, and PSMA in human prostate cancer models.
    Denmeade SR; Sokoll LJ; Dalrymple S; Rosen DM; Gady AM; Bruzek D; Ricklis RM; Isaacs JT
    Prostate; 2003 Mar; 54(4):249-57. PubMed ID: 12539223
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro modulation of tumor progression-associated properties of hormone refractory prostate carcinoma cell lines by cytokines.
    Sokoloff MH; Tso CL; Kaboo R; Taneja S; Pang S; deKernion JB; Belldegrun AS
    Cancer; 1996 May; 77(9):1862-72. PubMed ID: 8646686
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antiandrogenic effects of novel androgen synthesis inhibitors on hormone-dependent prostate cancer.
    Long BJ; Grigoryev DN; Nnane IP; Liu Y; Ling YZ; Brodie AM
    Cancer Res; 2000 Dec; 60(23):6630-40. PubMed ID: 11118046
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.